0
Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos – TheStreet.com
|
Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos
TheStreet.com LEXINGTON, Mass. (TheStreet) –Hedge fund manager Martin Shkreli has taken a 5.8% ownership stake in Amag Pharmaceuticals(AMAG), an escalation of his effort to wrest control of the struggling drug maker and … Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG … |





